143 related articles for article (PubMed ID: 37421880)
1. Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies.
Feng LR; Vogel A; Mellergaard C; Waldemar G; Hasselbalch SG; Law I; Henriksen OM; Frederiksen KS
J Neurol Sci; 2023 Aug; 451():120719. PubMed ID: 37421880
[TBL] [Abstract][Full Text] [Related]
2. The cingulate island sign in a mixed memory clinical cohort: Prevalence and diagnostic accuracy.
Feng LR; Waldemar G; Hasselbalch SG; Vogel A; Henriksen OM; Law I; Frederiksen KS
Parkinsonism Relat Disord; 2024 May; 122():106062. PubMed ID: 38452445
[TBL] [Abstract][Full Text] [Related]
3. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer's disease.
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Anderberg L; Andersen BB; Bjerregaard E; Hejl AM; Høgh P; Hasselbalch SG
J Neurol Sci; 2020 Mar; 410():116645. PubMed ID: 31911283
[TBL] [Abstract][Full Text] [Related]
4. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Iizuka T; Kameyama M
Ann Nucl Med; 2016 Jul; 30(6):421-9. PubMed ID: 27098829
[TBL] [Abstract][Full Text] [Related]
5. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
6. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies.
Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K
J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036
[TBL] [Abstract][Full Text] [Related]
7. The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.
Lim SM; Katsifis A; Villemagne VL; Best R; Jones G; Saling M; Bradshaw J; Merory J; Woodward M; Hopwood M; Rowe CC
J Nucl Med; 2009 Oct; 50(10):1638-45. PubMed ID: 19759102
[TBL] [Abstract][Full Text] [Related]
8. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
[TBL] [Abstract][Full Text] [Related]
9. Evaluating 2-[
Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
[TBL] [Abstract][Full Text] [Related]
10. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
Iizuka T; Kameyama M
J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of the cingulate island sign ratio for differentiating dementia with Lewy bodies from Alzheimer's disease changes depending on the mini-mental state examination score.
Asahara Y; Kameyama M; Ishii K; Ishibashi K
J Neurol Sci; 2023 Dec; 455():122782. PubMed ID: 37976791
[TBL] [Abstract][Full Text] [Related]
13. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
14. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
15.
Whitwell JL; Graff-Radford J; Singh TD; Drubach DA; Senjem ML; Spychalla AJ; Tosakulwong N; Lowe VJ; Josephs KA
J Nucl Med; 2017 Apr; 58(4):632-638. PubMed ID: 27688479
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
17. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD.
Kantarci K; Boeve BF; Przybelski SA; Lesnick TG; Chen Q; Fields J; Schwarz CG; Senjem ML; Gunte JL; Jack CR; Min P; Jain M; Miyagawa T; Savica R; Graff-Radford J; Botha H; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Petersen RC; Lowe VJ
Neuroimage Clin; 2021; 31():102754. PubMed ID: 34252877
[TBL] [Abstract][Full Text] [Related]
18. Optimized Cingulate Island Sign in Discriminating Dementia With Lewy Bodies From Alzheimer Disease.
Ge J; Lin H; Chen K; Wang M; He Z; Lu J; Ju Z; Sun Y; Liu F; Guan Y; Zhao Q; Zuo C; Wu P
Clin Nucl Med; 2023 May; 48(5):400-403. PubMed ID: 36947853
[TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies: basis of cingulate island sign.
Graff-Radford J; Murray ME; Lowe VJ; Boeve BF; Ferman TJ; Przybelski SA; Lesnick TG; Senjem ML; Gunter JL; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K
Neurology; 2014 Aug; 83(9):801-9. PubMed ID: 25056580
[TBL] [Abstract][Full Text] [Related]
20. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]